Chinese biotech Avistone Pharmaceuticals raises $200 mn for integrated oncology platform
The funding round was led by Vivo Capital...
Tag : biotechnology
Pfizer to buy remaining shares of Trillium Therapeutics for $2.26 bn
by WebAdmin
Pfizer will buy the shares for $18.50 a piece, representing a 203.8% premium...
Is the rise of biotechnology Covid-19 induced?
by WebAdmin
According to McKinsey, between 2019 and 2020, biotech saw double-digit annual growth in fundraising from VCs...
Mainz-based BioNTech to develop malaria vaccines with mRNA tech
by WebAdmin
The same technology was used to develop the Covid-19 vaccine...
Investing in Europe’s lucrative markets
With Brexit on the horizon, many smaller businesses in the UK are frightful of European expansion. However, with more consumers beginning to recognise brands around the world, international expansion is a lucrative decision for a range of sectors...
Demographic shifts creating opportunities for biotechnology
Global demographic changes lead the way for the sector’s growth...
Is there something like better tobacco?
Biotechnology firm opens up new opportunities for the multi-billion dollar market David Drake October 31, 2014: As the biotech firm 22nd Century Group, Inc. (NYSE MKT: XXII) rang the closing bell on the New York Stock Exchange last Thursday, the multi-billion dollar tobacco industry is at the threshold of this firm’s biotechnological efforts as it...